Top Markets
Coin of the day
Millendo Therapeutics, Inc. Millendo Therapeutics, Inc.

Millendo Therapeutics, Inc.

MLND
Kedudukan dalam Saham #40620
Millendo Therapeutics, Inc. is an advanced biopharmaceutical firm dedicated to... Millendo Therapeutics, Inc. is an advanced biopharmaceutical firm dedicated to developing innovative therapies for rare hormonal disorders, primarily within the United States. The company's key therapeutic candidates include livoletide, an investigational drug aimed at Prader-Willi syndrome; nevanimibe, an experimental compound designed for patients with classic congenital adrenal hyperplasia; and MLE-301, a neurokinin 3-receptor antagonist intended to alleviate vasomotor symptoms (such as hot flashes) in women experiencing menopause. This enterprise maintains its primary operational base in Ann Arbor, Michigan.
Harga Saham
$1.06
Disegerakkan terakhir: 2021-06-25
Modal Pasaran
$110.93K
Perubahan (1 hari)
-5.36%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Millendo Therapeutics, Inc. (MLND)

Kategori

Harga MLND dengan permodalan pasaran b
Millendo Therapeutics, Inc. Millendo Therapeutics, Inc.
MLND
$1.06
Modal pasaran bagi Millendo Therapeutics, Inc.(MLND)
Modal Pasaran: $110.93K
Sehingga August 2026, Millendo Therapeutics, Inc. mempunyai modal pasaran sebanyak $110.93K. Ini menjadikan Millendo Therapeutics, Inc. syarikat ke-40620th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Millendo Therapeutics, Inc. dari 2018 hingga 2026
MLND berbanding dengan 5 teratas yang paling popular stocks
Harga MLND Aset B Pasaran B Hasilnya
Millendo Therapeutics, Inc. Millendo Therapeutics, Inc.
$52,228,960 $110.93K
$5.466T +4,927,260,279.94%
Millendo Therapeutics, Inc. Millendo Therapeutics, Inc.
$42,596,687 $110.93K
$4.458T +4,018,555,252.36%
Millendo Therapeutics, Inc. Millendo Therapeutics, Inc.
$39,895,575 $110.93K
$4.175T +3,763,733,361.94%
Millendo Therapeutics, Inc. Millendo Therapeutics, Inc.
$35,055,814 $110.93K
$3.669T +3,307,152,137.52%
Millendo Therapeutics, Inc. Millendo Therapeutics, Inc.
$27,266,235 $110.93K
$2.853T +2,572,286,234.62%